Growth Metrics

Nexalin Technology (NXL) EPS (Weighted Average and Diluted) (2022 - 2025)

Nexalin Technology has reported EPS (Weighted Average and Diluted) over the past 4 years, most recently at -$0.13 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.13 for Q4 2025, up 53.57% from a year ago — trailing twelve months through Dec 2025 was -$0.51 (up 37.8% YoY), and the annual figure for FY2025 was -$0.5, up 39.76%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.13 at Nexalin Technology, roughly flat from -$0.13 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for NXL hit a ceiling of -$0.03 in Q3 2022 and a floor of -$0.31 in Q3 2023.
  • Median EPS (Weighted Average and Diluted) over the past 4 years was -$0.13 (2025), compared with a mean of -$0.15.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 933.33% in 2023 and later skyrocketed 53.57% in 2025.
  • Nexalin Technology's EPS (Weighted Average and Diluted) stood at -$0.11 in 2022, then increased by 9.09% to -$0.1 in 2023, then plummeted by 180.0% to -$0.28 in 2024, then skyrocketed by 53.57% to -$0.13 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.13 (Q4 2025), -$0.13 (Q3 2025), and -$0.1 (Q2 2025) per Business Quant data.